Ischemic Optic Neuropathy Clinical Trial
Official title:
The Detection and Epidemiology of NAION in a Commercially Insured Population in the United States.
The objectives of this study were to: (1) evaluate the natural history of non-arteritic anterior ischemic optic neuropathy (NAION); (2) estimate the population incidence of NAION; and (3) identify potential risk factors for NAION.
The study population consisted of members of the Ingenix Normative Health Informatics (NHI) Database during 01/01/2003 through 12/31/2007, who were 18 years of age or older with at least 183 days of continuous enrollment in the database and without any doctor visits associated with a diagnosis of ischemic optic neuropathy during the 183 days prior to cohort entry. From the study population, patients with a claim associated with an ischemic optic neuropathy diagnosis code were identified as potential NAION cases (n = 3,732). From the potential NAION cases, definite and possible NAION cases were identified using medical record review and a claims algorithm (n=1,283). From the study population, patients without a claim associated with an ischemic optic neuropathy diagnosis code were randomly selected as controls (n = 20,000) ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT02643615 -
Safety and Efficacy of Using SightSaver Visual Evoked Potential (VEP) for VEP Monitoring in Prone Spine Surgery
|
N/A | |
Active, not recruiting |
NCT00000126 -
Ischemic Optic Neuropathy Decompression Trial Followup (IONDT Followup)
|
N/A | |
Completed |
NCT00000127 -
Ischemic Optic Neuropathy Decompression Trial (IONDT)
|
Phase 3 | |
Recruiting |
NCT03475173 -
New Non-invasive Modalities for Assessing Retinal Structure and Function
|
N/A | |
Completed |
NCT00450294 -
Intraocular Pressure During Abdominal Aortic Aneurysm (AAA) Repair
|
N/A | |
Withdrawn |
NCT01607671 -
Treatment Study for Ischemic Optic Neuropathy With Opthalmic Timolol Maleate 0.5%
|
Phase 1 | |
Recruiting |
NCT03851562 -
Intravenous Infusion of Prostaglandins as Therapy in Patients With Anterior Non-arteritic Ischemic Optic Neuropathy
|
Phase 2 | |
Recruiting |
NCT05353413 -
Diffusion Weighted Magnetic Resonance Imaging and the Optic Nerve Neuropathy.
|
N/A | |
Recruiting |
NCT02377271 -
ENDOTHELION Study Group: Effect of Bosentan in NAION Patients
|
Phase 3 |